Form 8-K · Current Report · Filed 2024-11-13
Centene Corporation Announces Investor Meeting and Reaffirms 2024 Earnings Guidance
On November 13, 2024, Centene Corporation announced that its senior management team will meet with investors to reaffirm the Company's 2024 full-year adjusted diluted earnings per share (EPS) guidance of greater than $6.80, as previously provided on October 25, 2024.
- Filer
- Centene Corporation CNC · NYSE
- Filed
- Accession
- 0001071739-24-000208
- CIK
- 0001071739
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
The Company also expects to grow adjusted diluted EPS in 2025 and beyond. The meeting includes a presentation of non-GAAP financial measures to provide investors with a more accurate assessment of the Company's ongoing operations and performance.
Items reported
Regulation FD Disclosure
Market reaction
Close before filing
$58.60
Next session
+0.1%
Since filing
+6.2%
Latest close
$62.22
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from CNC reporting the same item, with the next session's move:
About Centene Corporation
Centene Corporation is a diversified healthcare enterprise providing a comprehensive range of managed care services to government-sponsored healthcare programs. Specializing in serving uninsured and underinsured populations, Centene offers health plans, benefits management, and other related services. It operates through two primary segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through Medicaid, Medicare Advantage, and the Health Insurance Marketplace, impacting millions of lives across the United States. Meanwhile, the Specialty Services segment enhances healthcare quality and affordability through offerings such as pharmacy solutions, behavioral health, and optometry services. Founded in 1984 and headquartered in St. Louis, Missouri, Centene plays a significant role in the healthcare sector by addressing accessibility and cost challenges, thereby shaping market trends and influencing policy developments. As a major participant in the managed care industry, Centene is crucial for promoting coordinated care and improving health outcomes for vulnerable populations.
Never miss another CNC filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.